Trial NCT03241017

View at ClinicalTrials.gov 
Org. Study IDs: IDA-D Trial

Last trial update was posted on 2018-04-09

MeSH Interventions

Durvalumab

MeSH Conditions

Lymphoma Lymphoma, Large B-Cell, Diffuse

Other Conditions


Stopping Reasons

Celgene withdrew the support for this study (Durvalumab cannot be provided)

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID